|
| Occurrence of both Islet cell and Insulin autoantibodies | Absence of both Islet cell and Insulin autoantibodies | Total | Relative Risk (95% CI) | P-Value |
| Risk Group (Newly Diagnosed Type 1 Diabetics) | 5 | 0 | 5 | 125.0 (40.89 - 125.0) | 0.00 |
| Non-Risk Group (Non-diabetic control) | 2 | 248 | 250 |
|
|
| Total | 7 | 248 | 255 |
|
|